Searchable abstracts of presentations at key conferences in endocrinology

ea0031p58 | Clinical practice/governance and case reports | SFEBES2013

De Novo HNF1b mutation as a cause for chronic treatment-resistant hypomagnesaemia

Stiles Craig , Kumar Ajith , Bockenhauer Detlef , Korbonits Marta

A 29y female presented with an 8y history of hypomagnesaemia. It was noted incidentally when hospitalised with mumps-related pancreatitis. Subsequently symptomatic hypomagnesaemia, with headaches and lethargy, was treated with magnesium glycerol phosphate 4 mg TDS, but she remained symptomatic with occasional need of IV Mg2+. It was thought that she was poorly compliant with her oral Mg2+ supplements. At presentation to our department for follow-up of her...

ea0031p206 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes

Kota Sunil Kumar , Ugale Surendra , Gupta Neeraj , Modi Kirtikumar D

Objective: To prospectively evaluate the results of laparoscopic ileal interposition (II) with diverted sleeve gastrectomy (DSG) for control of type 2 diabetes mellitus (T2DM) and related metabolic abnormalities.Methods: All patients underwent II+DSG. They had T2DM ≥5 years with poor glycemic control despite adequate dosage of oral hypoglycemic agents (OHAs) and/ or insulin. The primary outcome was remission of diabetes (HbA1C <6.5% without OHA...

ea0031p251 | Pituitary | SFEBES2013

Altitude acclimatization: plasma AVP response and physiological changes

Sachidhanandam Meenakshi , Kumar Salthan Ashok , Singh Som Nath , Ray UdaySankar

Background: Arginine vasopressin (AVP) changes during altitude acclimatization is of clinical interest as increases in their plasma levels (with reference to sea-level (SL)) have been associated with fluid retention accompanied by elevated plasma cortisol levels. Studies have reported no change/ decrease in plasma AVP during ‘normal’ acclimatization. This study was conducted to evaluate plasma AVP changes and the associated physiological changes during chronic exposu...

ea0031p388 | Thyroid | SFEBES2013

Myxedema Coma: an uncommon presentation of a common thyroid problem

Munir Atif , Hutchison Caroline , Kumar Balakrishna , Anthony Sony

Myxedema coma has very high mortality and should be suspected in an acutely unwell patient presenting with depressed mental status who is hypothermic, bradycardic and or hypotensive. Myxedema coma may be the first presentation of people with undiagnosed hypothyroidism. Definitive management is with thyroid hormone but supportive measures, identification and treatment of precipitating factors in an appropriately safe environment are vital. There is no consensus about preferred ...

ea0029p1074 | Neuroendocrinology | ICEECE2012

Mechanisms for the protective effects of 17-β-estradiol: relevance to depressive symptoms in Parkinson’s disease

Kumar P. , Kale R. , Cowsik S. , Baquer N.

Background: Parkinson’s disease (PD) is a neurodegenerative disease and a movement disorder characterized by loss of dopaminergic neurons in the substantia nigra causing dopamine depletion in the striatum. Neurodegeneration in PD occurs due to multiple pathways including oxidative stress, mitochondrial damage, protein aggregation. These changes increase during menopausal condition in females when the level of estradiol is decreased. Recently, there has been a growing inte...

ea0028p69 | Clinical practice/governance and case reports | SFEBES2012

An unusual case of hypercalcaemia as the presenting feature of pneumocystis jivorecii pneumonia (PCP)

Narayanaswamy Anil Kumar , Gibson Anthony , Okosieme Onyebuchi , Agarwal Neera

Case Summary: A 72 year-old man presented with a one month history of anorexia, weight loss, lethargy, constipation, increased thirst and generalised aches and pains. He had a background of hypertension, ischaemic heart disease, aortic stenosis, and a renal transplant 23 years ago with declining renal function. No significant abnormalities were noted on physical examination. Investigations confirmed hypercalcaemia, with serum calcium rising from 2.8–3.05 mmol/l. This was ...

ea0028p70 | Clinical practice/governance and case reports | SFEBES2012

Hypoglycaemia outbreak: a new danger on the streets?

Pura Narayanaswamy Anil Kumar , Williams Nia , Agarwal Neera , Okosieme Onyebuchi

Hypoglycemia is an uncommon clinical problem in patients without diabetes mellitus. Potential aetiologies include drugs, critical illness, hormone deficiencies, and non islet cell tumors. In the absence of these causes, the possibility of accidental, surreptitious, or even malicious hypoglycemia should be considered. We present three cases of severe, prolonged hypoglycemia occurring spontaneously in healthy young men without a history of diabetes mellitus or chronic illness. A...

ea0026p193 | Pituitary | ECE2011

Pituitary mycosis complicating a Cushing’s macroadenoma

Edirisinghe V , Goulden P , Powrie J , Kumar J

Introduction: A 59-year-old gentleman with longstanding poorly controlled type 2 diabetes mellitus, obesity, hypertension, obstructive sleep apnoea, depression and type 2 respiratory failure was seen in diabetes review clinic and noted to have truncal obesity, moon facies and wasting of the proximal muscles.Investigations: Urinary free cortisol was 782 nmol/24 h (NR <200). Midnight cortisol was 595 and 532 nmol/l on consecutive days. After low dose d...

ea0025cg1.1 | (1) | SFEBES2011

Pituitary apoplexy new society guidelines for treatment

Wass John , Kumar Senthil , Reddy Narendra , Vanderpump Mark , Baldeweg Stephanie

The guidelines for the treatment of pituitary apoplexy have now been published in Clinical Endocrinology (Clin Endocrinol 2011 Jan;74(1):9–20). These resulted from a group set up during the London pituitary multidisciplinary meeting.Classical pituitary apoplexy is a medical emergency and rapid replacement with hydrocortisone maybe life saving. It is a clinical syndrome characterised by the sudden onset of headache, vomiting, visual imp...

ea0024p35 | (1) | BSPED2010

NAFLD in type 1 DM: a report of 2 cases

Kumar P , Ghatak A , Blair J C , Didi M , Paul P

Introduction: Non-alcoholic steatohepatitis (NASH) is part of the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH commonly occurs in patients with type 2 DM and is less recognised in type 1 DM. The natural history of NASH in adult patients suggests potential development of progressive fibrosis and cirrhosis. However, secondary glycogenosis, commonly occurs in type 1 DM, is reversible when good glycaemic control is achieved, but may be misidentified as NASH b...